UK updated guidance on banned breast implant still goes against French position
This article was originally published in RAJ Devices
The UK Medicines and Healthcare products Regulatory Agency has issued updated guidance related to the banned Poly Implant Prothèse (PIP) silicone breast implants, which remains in stark contrast with the recent recommendations of French regulatory authority Afssaps1.
You may also be interested in...
Genfit will delay unblinding of data from its nearly complete Phase III study of elafibranor to get insight from the FDA on statistical methods in order to optimize its NDA.
Revolution has just one drug in the clinic, but its focus on KRAS excited IPO investors. Also, Deciphera’s $175m offering leads recent follow-ons and Spruce raises $88m in venture capital.
New real-world data, presented at a recent diabetes conference in Madrid, showed that Abbott's FreeStyle Libre system provided several clinical benefits for patients with diabetes.